May 8-9, 2015

COURSE DIRECTOR

Joachim Yahalom MDCHAIRMAN International Lymphoma Radiation Oncology Group MEMBER AND PROFESSOR Memorial Sloan Kettering Cancer Center

CONFERENCE LOCATION

Memorial Sloan Kettering Cancer CenterZUCKERMAN RESEARCH CENTER417 East 68th Street, New York (Between First and York Avenues)

NEW YORK CITY

Register today at:www.mskcc.org/lymphomaradiation

Modern Radiation For Lymphoma

UPDATED ROLE AND NEW RULES

T A R G E T I N G C A N C E R C A R E

®

COURSE DIRECTOR

Joachim Yahalom MD Chairman, International Lymphoma Radiation Oncology Group Member and Professor, MSK

HONORARY SPEAKERS

Saul Rosenberg MD Stanford, CA, USA

Samuel Hellman MD Chicago, IL, USA

INVITED SPEAKERS

Riccardo Dalla-Favera MD New York, NY, USA

Andreas Engert MD Cologne, Germany

Nancy Lee Harris MD Boston, MA, USA

Gerhard Held MD Saarland, Germany

Register today at:

www.mskcc.org/lymphomaradiation

COURSE OVERVIEWPresentations of advances in clinical options and translational research for various lymphomas and clinical scenarios with a focus on the updated role of radiotherapy, modern RT technologies, and new guidelines for RT dose and fields.

Six travel grants will be awarded in the amounts of $500 for participants from North America and $1000 for participants from other continents.

This program has been organized by The International Lymphoma Radiation Oncology Group and Memorial Sloan Kettering Cancer Center

This program is co-sponsored by the American Society For Radiation Oncology

This program has been endorsed by the European Society For Radiotherapy & Oncology

T A R G E T I N G C A N C E R C A R E

®

COURSE DIRECTOR

Joachim Yahalom MD Chairman, International Lymphoma Radiation Oncology Group Member and Professor, MSK

MSK SPEAKERS

Lisa DeAngelis, MD

Ahmet Dogan, MD, PhD

Steve Horwitz, MD

Craig Moskowitz, MD

Carol Portlock, MD

Anas Younes, MD

Andrew Zelenetz, MD, PhD

ILROG FACULTY SPEAKERS

Berthe Aleman, MD, PhD Amsterdam, The Netherlands

Louis S. Constine, MD Rochester, NY, USA

Bouthaina Dabaja, MD Houston, TX, USA

Hans T. Eich, MD, PhD Münster, Germany

David Hodgson, MD Toronto, Ontario, Canada

Bradford Hoppe, MD Jacksonville, FL, USA

Richard Hoppe, MD Stanford, CA, USA

Theodore Girinsky, MD Paris, France

Tim Illidge, MD, PhD Manchester, England, UK

Youlia Kirova, MD Paris, France

Yexiong Li, MD Beijing, China

Peter Mauch, MD Boston, MA, USA

George Mikhaeel, MD London, England, UK

Andrea Ng, MD Boston, MA, USA

Rahul Parikh, MD New York, NY, USA

Umberto Ricardi, MD Torino, Italy

Lena Specht, MD, PhD Copenhagen, Denmark

Stephanie Terezakis, MD Baltimore, MD, USA

Richard Tsang, MD Toronto, Ontario, Canada

Andrew Wirth, MD East Melbourne, Victoria, Australia

SCIENTIFIC AGENDA: MODERN RADIATION FOR LYMPHOMA UPDATED ROLE AND NEW RULES

Register today at:

www.mskcc.org/lymphomaradiation

SCIENTIFIC AGENDA: MODERN RADIATION FOR LYMPHOMA UPDATED ROLE AND NEW RULES

Register today at:

www.mskcc.org/lymphomaradiationT A R G E T I N G C A N C E R C A R E

®

Friday, May 8: Morning7:00-8:00am REGISTRATION AND BREAKFAST

INTRODUCTION SESSIONS 8:00-8:10am INTRODUCTION

Joachim Yahalom, MD

8:10-8:20am WELCOME Jose Baselga, MD, Physician in Chief, MSK

8:20-9:00am MEDICINE AND RADIATION ONCOLOGY GRAND ROUNDS ILROG KEYNOTE LECTURE “Milestones in the Treatment of Hodgkin Lymphoma: What’s Next?” Andreas Engert, MD

9:00-9:15am End of Grand Rounds (short break)

9:15-9:30am Introduction of Saul Rosenberg, MD Richard Hoppe, MD

9:30-10:00am Hodgkin’s Disease: A 50-Year Perspective Saul Rosenberg, MD

10:00-10:15am COFFEE BREAK

PATHOLOGY & IMMUNOLOGY SESSION MODERATOR: Ahmet Dogan, MD, PhD

10:15-10:35am WHO Lymphoma Classification Update Nancy Lee Harris, MD

10:35-11:05am “Hot” Issues in Lymphoma Pathology: Impact of Genomic Studies on Diagnosis of Lymphoma Ahmet Dogan, MD, PhD

11:05-11:35am Molecular Pathogenesis of B Cell Lymphoma Ricardo Dalla-Favera, MD

11:35am-12:00pm Immunological Modulation in the Treatment of Lymphoma: Present and Future Tim Illidge, MD, PhD

SCIENTIFIC AGENDA: MODERN RADIATION FOR LYMPHOMA UPDATED ROLE AND NEW RULES

Register today at:

www.mskcc.org/lymphomaradiationT A R G E T I N G C A N C E R C A R E

®

Friday, May 8: Afternoon12:00-1:00pm LUNCH AND DIGITAL POSTER PRESENTATION

1:00-3:00pm HODGKIN LYMPHOMA: ROLE OF RADIATION MODERATOR: Peter Mauch, MD

1:00-1:10pm Introduction of Samuel Hellman, MD Peter Mauch, MD

1:10-1:40pm What Thomas Hodgkin Can Teach Us Samuel Hellman, MD

1:40-2:00pm Staging and Response Assessment in Lymphoma George Mikhaeel, MD

2:00-2:20pm EORTC H10 and Future European Studies Lena Specht, MD, PhD

2:20-2:40pm HD6 and RAPID Study: Should It Change Practice? Tim Illidge, MD, PhD

2:40-3:00pm Survival Analysis in Hodgkin Lymphoma: Large Data Bases Rahul Parikh, MD

3:00-3:15pm COFFEE BREAK

3:15-4:15pm LOW RT DOSE STRATEGIES MODERATOR: Richard Tsang, MD

3:15-3:40pm Primary CNS Lymphoma Lisa DeAngelis, MD

3:40-4:00pm Indolent Lymphomas Andrew Wirth, MD

4:00-4:15pm COFFEE BREAK

4:15-5:15pm CASE DISCUSSION: HODGKIN LYMPHOMA MODERATOR: David Hodgson, MD

4:15-5:15pm CASE DISCUSSION PANELISTS: Stephanie Terezakis, MD; Hans T. Eich, MD, PhD; Carol Portlock, MD; Peter Mauch, MD; Youlia Kirova, MD

SCIENTIFIC AGENDA: MODERN RADIATION FOR LYMPHOMA UPDATED ROLE AND NEW RULES

Register today at:

www.mskcc.org/lymphomaradiationT A R G E T I N G C A N C E R C A R E

®

Saturday, May 9: Morning7:00-8:00am BREAKFAST

AGGRESSIVE LYMPHOMAS MODERATOR: Bouthaina Dabaja, MD

8:00-8:20am Biomarker Driven Treatment Selection in DLBCL Andrew Zelenetz, MD, PhD

8:20-8:40am The Role of Radiotherapy in the Treatment of DLBCL: A Perspective of The German High-Grade Non-Hodgkin Lymphoma Study Group Gerhard Held, MD

8:40-9:00am More Evidence of Benefit (and less toxicity) for Radiation Therapy in Large-Cell Lymphoma Bouthaina Dabaja, MD

9:00-9:20am High Dose Salvage for Non Hodgkin Lymphoma and Hodgkin Lymphoma Craig Moskowitz, MD

9:20-9:45am New Treatment Options in Lymphoma Anas Younes, MD

9:45-10:00am COFFEE BREAK SKIN AND T-CELL LYMPHOMAS

MODERATOR: Richard Hoppe, MD

10:00-10:20am Systemic Therapy for T-Cell Lymphoma Steve Horwitz, MD

10:20-10:40am Prognosis and Treatment of Extranodal NK/T-Cell Lymphoma, Nasal-Type Yexiong Li, MD

10:40-11:00am Radiotherapy of Mycosis Fungoides Richard Hoppe, MD

11:00am-12:30pm CASE DISCUSSION: NON-HODGKIN LYMPHOMA MODERATOR: Bouthaina Dabaja, MD

11:00am-12:30pm CASE DISCUSSION PARTICIPANTS: Anas Younes, MD; Gerhard Held, MD; Richard Tsang, MD; Yexiong Li, MD

SCIENTIFIC AGENDA: MODERN RADIATION FOR LYMPHOMA UPDATED ROLE AND NEW RULES

Register today at:

www.mskcc.org/lymphomaradiationT A R G E T I N G C A N C E R C A R E

®

Saturday, May 9: Afternoon12:30-2:00pm LUNCH AND DIGITAL POSTER PRESENTATION

12:30-2:00pm LUNCH AND MEETING OF THE STEERING COMMITTEE AND COUNCIL

2:00-3:00pm NEW FIELDS CONCEPT AND NEW TECHNOLOGY MODERATOR: Umberto Ricardi, MD

2:00-2:20pm Concepts of ISRT and DIBH Theodore Girinsky, MD

2:20-2:40pm IMRT / IGRT Techniques: How Do We Decide About It? Umberto Ricardi, MD

2:40-3:00pm Proton Therapy for Lymphoma: Pros and Cons Bradford Hoppe, MD

3:00-3:20 pm COFFEE BREAK

LONG-TERM COMPLICATIONS MODERATOR: Berthe Aleman, MD, PhD

3:20-3:40pm Second Malignancies Berthe Aleman, MD, PhD

3:40-4:00pm The Heart after Lymphoma Therapy: The Beat Goes On (usually)! Louis S. Constine, MD

4:00-4:20pm Surveillance and Prevention of Long-Term Morbidity Andrea Ng, MD

4:20-4:30pm CONCLUSION Joachim Yahalom, MD

SCIENTIFIC AGENDA: MODERN RADIATION FOR LYMPHOMA UPDATED ROLE AND NEW RULES

Register today at:

www.mskcc.org/lymphomaradiationT A R G E T I N G C A N C E R C A R E

®

On the evening of Friday, May 8, join us to “Celebrate New York” at the Museum of the City of New York!Included for you and a guest is a cocktail reception, dinner, and private tour of the galleries.

www.MCNY.orgRSVP by Thursday, April 30

www.surveymonkey.com/s/2015ILROGDinner

Saturday, May 9, 2015

ILROG LEADERSHIP DINNERMetropolitan Museum of Art

1000 5th Avenue, New York

6:30pm Cocktail Reception7:15pm Dinner

REGISTRATIONEARLY BIRD* GENERAL

$250 $350 MDs, PhDs and DOs

$50 $50 Fellows, Residents and RNs * Deadline is March 1, 2015.

Registration fee includes an electronic syllabus and other related hand-out materials, continental breakfast, lunch, and refreshment breaks. Special meals are available upon request, including vegetarian, kosher, or gluten-free. Please let us know if we can assist you with special dietary needs.

For more information or to register to attend please go to:

www.mskcc.org/lymphomaradiationOr contact the:

OFFICE OF CONTINUING MEDICAL EDUCATIONMemorial Sloan Kettering Cancer Center633 Third Avenue, 12th floor, New York, New York 10017

(646) 227-2025 • brodheap@mskcc.org

TARGET AUDIENCERadiation oncologists and other health care professionals involved in treating patients with lymphoma.

COURSE DESIGNPresentations of advances in clinical options and translational research for various lymphomas and clinical scenarios with a focus on the updated role of radiotherapy, modern RT technologies, and new guidelines for RT dose and fields.

EVALUATIONA course evaluation survey sent out electronically will provide attendees with the opportunity to review the sessions and the speakers and to identify future educational needs.

ACCREDITATION STATEMENTMSK is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA CREDIT DESIGNATION STATEMENTMSK designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity. The AMA has determined that physicians not licensed in the United States but who participate in this CME activity are eligible for 13.5 AMA PRA Category 1 Credit(s)™.

FACULTY DISCLOSURE It is the policy of MSK to make every effort to insure balance, independence, objectivity, and scientific rigor in all continuing medical education activities which it sponsors as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity sponsored by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational.

OUTCOMES MEASUREMENT SURVEYSix months after the end of the course an Outcomes Measurement Survey will be sent to all participants to help us determine what positive impacts have been made on participant practice as a result of the course.

HOTEL RESERVATIONSFor hotel availability and special rates close to MSK, go to: www.mskcc.org/accommodations. Please feel free to contact the CME Office for further assistance as needed at: johnsonf@mskcc.org

2015

HPV and The Cancer Connection April 8

Multidisciplinary Spine Apr 17 Oncology Symposium

LGBT Allies Training April (TBD)

SCLC Conference April 22-24

Pelvic MRI Course April 27-29

Overuse: A Quality Problem April 29 In and Out of The Hospital

Care of the Older Adult Across May 1 The Cancer Continuum Symposium

LGBT Health Workforce May 1-3

Pathology of Neoplastic Disease May 4-8

Modern Radiation for May 8, 9 Lymphoma

Radioactive Seed Localization May 11

Oncologic Imaging May 14-16

Thrombosis and Hemostasis May 17

SPARC May 19

Ovarian Cancer June 5-6

Trudy N. Small Symposium June 19

Thoracic Pathology NYC September 11-13

Robotics (w/ MDACC) September 17-18

Endobronchial Ultrasound September 24-25 Interventional Bronchoscopy

Thoracic Surgical Oncology October 2-3

Oncologic FDG PET/CT October 9-10

Genetics and Genomics of October 15-16 Gynecologic Cancers

Defining the Actionable Genome October 16-17

Spotlight On ALL October 18

Dermatology Through The October 22 Lens of Medical Informatics

Dermatologic Care October 23

Dermoscopy Intermediate October 23-24

Musculoskeletal Tumor Pathology October 23-25

Urologic Cancers October 29-31

Complex Skin Cancers November 20-22

International Ovarian Cancer December 4-5

Please be sure to mark your calendars for

upcoming

2015 MSK CMECOURSESACCREDITATION STATEMENT

MSK is accredited by the Accreditation Council for

Continuing Medical Education to sponsor continuing medical

education for physicians.

To register or for more information, contact:

OFFICE OF CONTINUING MEDICAL EDUCATION

Memorial Sloan Kettering Cancer Center

633 Third Avenue, 12th Floor, New York, New York 10017

(646) 227-2025 brodheap@mskcc.org

Or register online: www.mskcc.org/cme

For course updates, follow:

facebook.com/mskcmeor on Twitter: @mskcme